These are a type of cancer that starts in the nervous system. They usually appear in babies and young children. The name 'primitive' means the cells look immature, like they haven't fully developed. These tumors can be very aggressive and are often found in the brain or spinal cord.
Every report comes from a Lived member, sent anonymously.
Have you had Craniotomy for Primitive Neuroectodermal Tumors?
Primitive neuroectodermal tumors (PNETs) are rare, fast-growing cancers made of immature cells that resemble the early cells of the developing nervous system. When they arise in the brain or spinal cord (CNS-PNET), they belong to a larger family called central nervous system (CNS) embryonal tumors. Most occur in children, often young children, and they tend to spread through the cerebrospinal fluid, the fluid that bathes the brain and spinal cord. As they grow, they often block that fluid's flow and raise pressure inside the skull, which causes headaches, vomiting and problems with balance or vision. PNET is now an older label. In 2016 the World Health Organization dropped CNS-PNET from its classification of brain tumors because tumors that looked alike under the microscope turned out to be several different diseases with different outlooks. Today they are named by their genetic features, for example embryonal tumor with multilayered rosettes (ETMR), CNS neuroblastoma or medulloepithelioma, and some tumors once called PNET prove to be other cancers, such as high-grade gliomas. The term also turns up in two other places. Medulloblastoma, a related tumor in the back of the brain, was sometimes called a PNET. A peripheral PNET, one that grows outside the brain and spinal cord, is the same tumor as Ewing sarcoma and is treated as such.
These tumors begin in cells left over from fetal development that grow out of control after genetic changes inside the tumor cells. In most children, nobody knows why those changes happened, and nothing a parent did or did not do is known to cause them. A small number of embryonal brain tumors are linked with inherited conditions. Some families are offered genetic counseling and testing, particularly when a related tumor such as medulloblastoma or pineoblastoma is involved, to see whether a predisposition is present and what it might mean for siblings or future cancer risk.
Symptoms usually come from a tumor pressing on the brain or blocking the flow of cerebrospinal fluid, which raises pressure inside the skull. They include headaches, often worse in the morning or eased by vomiting, nausea, unusual sleepiness, seizures, double vision, weakness and problems with balance. Infants may be irritable, feed poorly, fall behind on milestones or have a head that grows unusually fast. MRI (magnetic resonance imaging) of the brain and the whole spine, with a contrast dye, shows the tumor and whether it has spread. A lumbar puncture (spinal tap) checks the spinal fluid for tumor cells. The diagnosis is confirmed by removing tissue, usually during surgery to take out as much of the tumor as is safe. The tissue tests matter as much as the scans. Beyond looking under the microscope, pathologists use antibody stains and molecular tests that read the tumor's genetic changes, sometimes including DNA methylation profiling (a test that sorts tumors by chemical tags on their DNA). In one national trial, most tumors originally labeled CNS-PNET outside the pineal region (the area around the pineal gland, deep in the brain) turned out to be other tumor types, which is why getting a precise, current diagnosis, sometimes with a second pathology opinion, can change treatment and outlook.
Treatment is planned by a pediatric brain tumor team and usually combines surgery, radiation and chemotherapy. Surgery aims to remove as much tumor as can be taken out without causing serious harm, because in studies, removing all or nearly all of the tumor has been linked with better outcomes. Age shapes the rest of the plan. For children older than 3, surgery is usually followed by radiation to the whole brain and spinal cord (craniospinal radiation), since these tumors can seed along the spinal fluid, with chemotherapy given during and after radiation. In children 3 or younger, radiation can seriously affect brain development and growth, so chemotherapy is used to delay or avoid it. Some young children, and some with ETMR or medulloepithelioma, receive high-dose chemotherapy followed by a transplant of their own previously collected blood stem cells to help the bone marrow recover. The exact regimen depends on the specific tumor type, whether it has spread and how much was removed. Because these tumors are rare and their classification has changed, many children are treated within clinical trials, and families can ask whether one is available.
Treatment is intensive and often lasts many months. Children typically spend time in the hospital after surgery, go through a course of radiation treatments if radiation is part of the plan, and have repeated rounds of chemotherapy that lower blood counts and increase infection risk. Rehabilitation such as physical, speech or occupational therapy may be needed after surgery. Outlook varies widely with the exact diagnosis. In one trial, children whose tumors were confirmed as supratentorial embryonal tumors (in the upper, main part of the brain) or pineoblastoma (a tumor of the pineal gland) did considerably better than older figures for PNET suggested, with about four in five alive five years later. That was a small group, most of them with pineoblastoma. ETMR and medulloepithelioma remain much harder to treat, with most children not surviving five years. The care team can explain what the specific findings mean for one child. After treatment, MRI scans continue on a schedule because these tumors most often return within the first three years, though they can come back later. Survivors also need long-term follow-up for late effects, which can include slower growth, hormone and thyroid problems, hearing loss, heart effects, difficulties with learning, memory and attention, and a higher risk of second cancers. School support and survivorship clinics help families manage these over time.
Call 911 or go to the emergency room if a child is very hard to wake or newly confused, has a severe headache with repeated vomiting, or has a seizure, especially a first seizure or one that does not stop. These can mean dangerous pressure on the brain from blocked spinal fluid, including a blocked drainage tube (shunt) in a child who has one. During chemotherapy, call the care team right away for a fever of 100.5 F (38 C) or higher, chills or other signs of infection, since infections at this stage can become life threatening quickly. Arrange a prompt visit with a doctor if a child has headaches that keep returning, especially in the morning or with vomiting, new problems with balance or walking, double vision, more sleepiness than usual, or, in an infant, a rapidly enlarging head or lost milestones. These symptoms have many other causes, but they deserve evaluation. Between scheduled visits after treatment, report any return of earlier symptoms or new weakness so the team can decide whether an earlier scan is needed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Primitive Neuroectodermal Tumors is like, what's helped you, or ask the community a question.